Leal Health

AI-based Decision Support Platform for Cancer Treatment

Health Tech & Life Sciences
Acquired by Nexus Precision Health on Feb 2026
Acquired Tel Aviv-Yafo Founded 2017
Total raised
$54.2M
Last: Series B 2024-04
Stage
Acquired
Founded
2017
Headcount
21
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Leal Health is a growing patient-first, AI-powered decision support platform dedicated to expediting access to all available advanced cancer treatments.

Working directly with patients, healthcare providers, and pharmaceutical companies, Leal Health provides patients with instant access to precise, advanced cancer treatment while also enabling the pharmaceutical and biotech industries to develop patient-centric clinical trials and provide real-time analytics and understanding of patient barriers and motivations.

Leal Health was chosen as one of TIME magazine’s “100 Best Inventions of 2020,” was named an honoree in Fast Company’s 2021 “World-Changing Ideas Awards” in the AI and data category, and recognized as the “Leader in Patient Recruitment and Enrollment” by CBInsights.

Funding history · 5 rounds · $54.2M total

2024-04
Series B $26.0M
2022-02
Series A $20.0M
2021-02
Series A $5.0M
2019-12
Seed $2.7M
Date unknown
Undisclosed $500K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient EngagementRetail PlatformsServices
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business model
B2BB2B2C

Highlights

Verified

Tags

saasdecision-supportmachine-learningpatientspharma-companiesoncologymarketplaceactionable-insightsartificial-intelligencedoctorscancernatural-language-processingdeep-learningdigital-healthcareweb-platformclinical-datapatient-engagementclinical-trials